| Literature DB >> 32630741 |
Hayato Tanabe1, Haruka Saito1, Akihiro Kudo1,2, Noritaka Machii1, Hiroyuki Hirai1,3, Gulinu Maimaituxun1, Kenichi Tanaka4, Hiroaki Masuzaki5, Tsuyoshi Watanabe6, Koichi Asahi7, Junichiro Kazama4, Michio Shimabukuro1.
Abstract
Diabetes is a complex and heterogeneous disease, making the prediction of the risks of diabetic complications challenging. Novel adult-onset diabetes subgroups have been studied using cluster analysis, but its application in East Asians remains unclear. We conducted a retrospective cohort study to elucidate the clinical utility of cluster-based subgroup analysis in the Japanese population. Cluster analysis based on anti-glutamate decarboxylase antibody (GAD antibody) levels, age at diagnosis, body mass index (BMI), hemoglobin A1c (A1c), and homeostatic model assessment 2 estimates of β-cell function and insulin resistance was performed in 1520 diabetic patients. The risk of developing diabetic complications was analyzed using Kaplan-Meier analysis and the Cox proportional hazards model. By cluster analysis, we identified five distinct subgroups of adult-onset diabetes in the Japanese population. The risk of diabetic complications varied greatly among the clusters. Patients with severe autoimmune diabetes or severe insulin deficiency diabetes were at an increased risk of diabetic retinopathy, and those with severe insulin resistant diabetes (SIRD) had the highest risk of developing diabetic kidney disease (DKD). After adjusting for uncorrectable and correctable risk factors, SIRD was found to be an independent risk factor for DKD. In conclusion, we identified five subgroups of adult-onset diabetes and the risk factors for diabetic complications in the Japanese population. This new classification system can be effective in predicting the risk of diabetic complications and for providing optimal treatment.Entities:
Keywords: chronic kidney disease; coronary artery disease; homeostasis model assessment (HOMA); retinopathy; type 2 diabetes
Year: 2020 PMID: 32630741 DOI: 10.3390/jcm9072083
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241